Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amplifier Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Amplifier Therapeutics

Amplifier Therapeutics

Series A

NYC-based Amplifier Therapeutics develops AMPK activators to treat aging-related disorders.

HQ
New York City, NY, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

Amplifier Therapeutics, founded in New York City, focuses on developing AMP-activated protein kinase (AMPK) activator molecules to treat aging-related disorders, including metabolic issues, cardiovascular diseases, kidney diseases, and cancer. Their core mission is to harness the broad therapeutic applications of AMPK activation to improve cellular metabolism and energy regulation, addressing the decline in AMPK signaling that occurs with age.

Notable figures affiliated with Amplifier Therapeutics include leading scientists and industry experts in biopharmaceuticals. The company has attracted significant interest from investors due to its innovative approach to treating chronic diseases. Key achievements include the development of proprietary AMPK activators that have shown promise in preclinical trials. Amplifier Therapeutics aims to make a substantial impact on the treatment of aging-related disorders, potentially improving the quality of life for millions.

Amplifier Therapeutics - Similar Companies

Amplifica logo

Amplifica

amplificabio.com

Amplicore logo

Amplicore

Amplo Biotechnology logo

Amplo Biotechnology

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Fountain Therapeutics logo

Fountain Therapeutics

fountaintx.com

Ammonett Pharma logo

Ammonett Pharma

AgeX Therapeutics logo

AgeX Therapeutics

Ampel Biosolutions logo

Ampel Biosolutions

Guardian Therapeutics logo

Guardian Therapeutics

Gerostate Alpha logo

Gerostate Alpha

Amphix Bio logo

Amphix Bio

amphixbio.com

Inflammasome Therapeutics logo

Inflammasome Therapeutics

inflam.com

Actuate Therapeutics logo

Actuate Therapeutics

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Amplifier Therapeutics - Quick Facts

Who are Amplifier Therapeutics' competitors?

Companies similar to Amplifier Therapeutics include Amplifica, Amplicore, Amplo Biotechnology and Akttyva Therapeutics.

When was Amplifier Therapeutics founded?

Amplifier Therapeutics was founded in 2001.

Where is Amplifier Therapeutics' headquarters located?

Amplifier Therapeutics' headquarters is located in New York City, NY, US.

When was Amplifier Therapeutics' last funding round?

Amplifier Therapeutics' most recent funding round was for $33.3M (USD) in October 2023.

How much has Amplifier Therapeutics raised to-date?

As of Oct 17, 2023, Amplifier Therapeutics has raised a total of $33.3M (USD).

How many employees does Amplifier Therapeutics have?

Amplifier Therapeutics has 50 employees as of Feb 4, 2024.

Amplifier Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Biotech
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified